James J. Crawford, A. R. J. (2018). Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development. American Chemical Society (ACS).
Chicago Style (17th ed.) CitationJames J. Crawford, Adam R. Johnson. Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development. American Chemical Society (ACS), 2018.
MLA (9th ed.) CitationJames J. Crawford, Adam R. Johnson. Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development. American Chemical Society (ACS), 2018.
Warning: These citations may not always be 100% accurate.